Role of NFDI4Microbiota in DeCOI

Under the umbrella of the “Deutsche COVID-19 OMICS Initiative” (DeCOI), NFDI4Microbiota researchers are collaborating with two partners: (1) the NFDI consortium “The German Human Genome-Phenome Archive” (GHGA) and (2) the “Nationwide Research Network – Applied Surveillance and Testing” (B-FAST) of the Network University Medicine (NUM). Together, they are developing the COGDAT database, meant to host SARS-CoV-2 data resulting from German viral surveillance efforts. NFDI4Microbiota is involved in all aspects, from the coordination of the effort to the development of data analysis workflows, visualisations, acquisition of diagnostic labs as data-providing partners, and implementation of the FAIR data principles.

NFDI4Microbiota participated in the workshop on the creation of data management plans (DMPs) and use of DMP tools

NFDI4Microbiota, represented by Justine Vandendorpe and Konrad Förstner, participated today in the workshop on the creation of data management plans (DMPs) and use of DMP tools organised by RDMO, the NFDI directorate and NFDI4Ing. The aim of the workshop was to discuss how to best set up, use and continue DMPs. A short presentation about NFDI4Microbiota was given during this workshop.

NFDI4Microbiota received feedback from the expert committee for its proposal and presentation

The NFDI4Microbiota consortium, which includes 10 co-applicants and more than 50 participants, participated in the second call for proposals for NFDI consortia at the end of September 2020. At the beginning of December 2020, the consortium presented and defended its proposal in front of an expert committee. Last week, the expert committee released their review which, to our delight, was outstanding and encouraging. The consortium sees this as a confirmation that it is on the right track, and is now looking forward to the next step of the selection process: the final decision on funding consortia to be taken in June 2021 by the Joint Science Conference (GWK).

Questionnaire to collect community feedback (3rd round)

NFDI4Microbiota strives to provide the German microbiology community with an infrastructure and services that closely reflect current and future researchers’ needs. We can only achieve this together with you. This is why, we kindly invite you to provide feedback to NFDI4Microbiota by filling in this 5 minute questionnaire by September 18, 2020. In advance, we thank you for your support!

Questionnaire to collect community feedback (2nd round)

NFDI4Microbiota strives to provide the German microbiology community with an infrastructure and services that closely reflect current and future researchers’ needs. We can only achieve this together with you. This is why, we kindly invite you to provide feedback to NFDI4Microbiota by filling in this 5 minute questionnaire by September 11, 2020. In advance, we thank you for your support!

Genomics researchers join forces in the German COVID-19 OMICS Initiative – DeCOI

How does the novel coronavirus (SARS-CoV-2) change its genetic material? What other infections do patients suffer from? Are there genetic predispositions to the coronavirus disease 2019 (COVID-19)? A number of genomics researchers are working hard to bring together their expertise and sequencing infrastructure to help manage the COVID-19 pandemic. In order to accelerate research, these activities are now officially combined in the German COVID-19 OMICS Initiative (DeCOI). Scientists from more than 22 institutes are already involved in DeCOI. The NFDI4Microbiota consortium and its members are actively contributing to this initiative.

NFDI4Microbiota supports the genome sequencing of SARS-CoV-2

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19), is now a global threat. Knowledge about COVID-19 must thus be extended immediately. Unfortunately, relatively few genome sequences of SARS-CoV-2 are currently publicly available. To improve this situation, NFDI4Microbiota and partner laboratories are offering to assist researchers in sample preparation, genome sequencing and assembly of SARS-CoV-2, as well as in immediate deposition of resulting sequences in public repositories.
The aim is to significantly increase the number of publicly accessible genome sequences of SARS-CoV-2. Further information can be found on the NFDI4Microbiota webpage SARS-CoV-2 genome sequencing. If you are interested in this service, please contact us at covid19-seq@ndfi4microbiota.de.